Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
9.29
-0.22 (-2.31%)
May 13, 2025, 4:00 PM - Market closed
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 619 employees as of December 31, 2024. The number of employees decreased by 90 or -12.69% compared to the previous year.
Employees
619
Change (1Y)
-90
Growth (1Y)
-12.69%
Revenue / Employee
$306,183
Profits / Employee
-$229,139
Market Cap
1.41B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ADPT News
- 12 days ago - Adaptive Biotechnologies Corporation (ADPT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Adaptive Biotechnologies Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewsWire
- 5 weeks ago - Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies Corporation (ADPT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - GlobeNewsWire